Robert Lippert

ZARS Pharma, Inc. develops and distributes drugs. It is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs, primarily for the treatment of pain, using its proprietary drug delivery technologies. The company was founded by Jie Zhang, Theodore H. Stanley, Larry D. Rigby and Michael A. Ashburn in 1996 and is headquartered in Salt Lake City, UT.

ProCertus BioPharm, Inc. operates as an oncology-based pharmaceutical company. Its product includes DermX, ProDermaCel, and OralX, proprietary pharmaceuticals which are designed to reduce or eliminate the side effects associated with cancer therapy. ProDermaCel will protect cancer patients from chemotherapy- and radiotherapy-induced alopecia (hair loss), DermX will prevent radiotherapy-induced dermatitis (skin burn), and OralX will protect against chemotherapy- and radiotherapy-induced oral mucositis. The company was founded by William E. Fahl and in 1997 and is headquartered in Madison, WI.

Exponential Biotherapies, Inc. discovers and develops drugs. It provides small molecule drugs to treat an inflammatory disorders, such as acute kidney injury, septic shock, radiation sickness, and avian influenza infections. The company was founded on July 31, 1996 and is headquartered in New York, NY.

Part of Atlas Copco AB, Ohmeda is a British company that manufactures equipment goods and gas pipeline systems. The company is based in Surrey, UK. Ohmeda was acquired by Atlas Copco Medical Ltd. on January 01, 1995 for $40.52 million.

Baxter Corp. supplies health care and laboratory products. Its products are used for treating cancer, hemophilia, immune deficiencies, kidney disease, and trauma. The company is headquartered in Mississauga, Canada

Ratio, Inc. is focused on the development of a drug delivery pump worn like a patch. The company is committed to producing low-cost, high compliance medical devices for enhancing patient care. Its product is a disposable drug delivery pump worn like a patch. The device acts as a platform for satisfying a broad range of demanding drug delivery applications. It is fully self-contained and small in size, making it convenient to wear and easy to hide. The key to this technology is the non-electronic, hydrogel-based pump that enables customized delivery profiles. There are several competing products that can deliver large molecule drugs; insulin pumps, needles, injector pens, and inhalers. Its product is fundamentally different because it is low-cost, painless, can administer a sustained delivery up to 24 hours, and delivers the drug into the skin. The company understands the rigorous demands of formulating a safe drug and is committed to making their administration as simple as possible.